Jan 14, 2016 by Brian Feroldi, Tyler Crowe, Matt DiLallo, Steve Symington, and Timothy Green5 Great Stocks on SaleOur contributors think the blue-light special is flashing over these five stocks.
Jan 13, 2016 by Brian Feroldi3 Stocks with Better Dividends Than CVS Health CorporationThinking about investing in CVS Health because of its dividend? Here are three other healthcare stocks you might want to consider instead.
Jan 13, 2016 by Brian FeroldiWhy Envision Healthcare Holdings Inc, Team Health Holdings Inc, and Community Health Systems Inc All Tanked TodayDownbeat earnings revision mixed with the overall market sell-off is weighing heavily on these stocks today.
Jan 13, 2016 by Brian FeroldiWhy MannKind Corportion Is Soaring TodayShares jump in anticipation of the company's upcoming investor presentation.
Jan 13, 2016 by Brian FeroldiWhy Bluebird Bio Inc.'s Stock Bounced BackShares rebound after traders had more time to adjust to the company's new data release schedule.
Jan 13, 2016 by Brian FeroldiWhy Idera Pharmaceuticals Inc. Shares Dropped 36% in 2015Clinical progress doesn't always translate into a higher share price.
Jan 12, 2016 by Brian Feroldi, Sean Williams, and Keith SpeightsThese Biotech Stocks Could Double in 2016Our healthcare contributors think these three stocks could offer 100% upside if all goes well.
Jan 12, 2016 by Brian Feroldi, Keith Speights, and Cheryl Swanson3 Biotech Stocks to Buy in JanuaryAre you looking to put money to work in the biotech sector? Here are three stocks our contributors like right now.
Jan 11, 2016 by Brian FeroldiShire PLC Spends $32 Billion on Baxalta Inc. -- An Arbitrage Opportunity?Potential tax concerns keep Mr. Market skeptical
Jan 11, 2016 by Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, and Matt Frankel, CFP4 Great Retirement Stocks to Buy in 2016Our top contributors think these four stocks are ideal choices for investors in retirement.
Jan 11, 2016 by Brian FeroldiWhy Pacific Biosciences of California Inc Is Down Big TodayA slower than hoped for launch of the company's new Sequel System is pressuring shares on Monday.
Jan 11, 2016 by Brian FeroldiWhy bluebird bio Inc's Stock Is Tanking TodayTraders are dumping shares after news broke that the company won't be providing a clinical update on its lead compound until the later half of the year.
Jan 11, 2016 by Brian FeroldiWhy Tetraphase Pharmaceuticals Dropped 74% of Its Value in 2015This is what happens when things don't go to according to plan.
Jan 10, 2016 by Brian FeroldiTheravance Inc. Stock Was Up 14% in December -- Here's WhyLow interest in the company's tender puts investors in a good mood.
Jan 10, 2016 by Brian FeroldiLast Week's Best Healthcare ETFOr perhaps a better title would be "least worst."
Jan 9, 2016 by Brian FeroldiBehind Alnylam Pharmaceuticals' December PlungeShares performed poorly in a month filled with good news.
Jan 9, 2016 by Brian FeroldiWhy Halozyme Therapeutics Inc. Rose 76% in 2015It was a banner year for the human enzyme specialist.
Jan 8, 2016 by Brian FeroldiWhy Valeant Pharmaceuticals Intl. Inc. Crashed in 2015It was a rough year for the controversial pharmaceutical company.
Jan 8, 2016 by Brian FeroldiNatera, Inc. Surged 20% Higher in December. Here's Why. News of the company gaining a foothold overseas puts investors in a good mood.
Jan 8, 2016 by Brian Feroldi, Matt DiLallo, and Andrés Cardenal3 Stocks Warren Buffett Should Buy in 2016Our contributors think these three stocks are classic Buffett investments.
